M. Macpherson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Shampa Das (5 shared papers)James G. Wright (4 shared papers)Paul Newell (2 shared papers)Todd Riccobene (3 shared papers)Glen Clack (3 shared papers)Neil J. Gallagher (3 shared papers)Timothy J. Carrothers (2 shared papers)Elizabeth B. Lamont (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)European Journal of Clinical Pharmacology (2 papers)Cancer Research (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
M. Macpherson
20 papers receiving 445 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 136
- Applied Microbiology and Biotechnology 45
- Pharmacology 173
- Oncology 129
- Epidemiology 113
Countries citing papers authored by M. Macpherson
This map shows the geographic impact of M. Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Macpherson more than expected).
Fields of papers citing papers by M. Macpherson
This network shows the impact of papers produced by M. Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Macpherson. The network helps show where M. Macpherson may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Macpherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 77 | |
| 2 | 2010 | 70 | |
| 3 | 2009 | 42 | |
| 4 | 2018 | 38 | |
| 5 | 2013 | 34 | |
| 6 | 2018 | 28 | |
| 7 | 2011 | 25 | |
| 8 | 2005 | 22 | |
| 9 | 2022 | 18 | |
| 10 | 2005 | 18 | |
| 11 | 2020 | 17 | |
| 12 | Results of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors | 2013 | 16 |
| 13 | 2024 | 11 | |
| 14 | A phase I multiple ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD0530, a highly selective, orally available, dual-specific Src-Abl kinase inhibitor | 2005 | 9 |
| 15 | 2005 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2004 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2004 | 3 | |
| 20 | 2009 | 1 |
About M. Macpherson
M. Macpherson is a scholar working on Molecular Biology, Pharmacology, Genetics, Pediatrics, Perinatology and Child Health and Oncology, having authored 21 papers that have together received 454 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Pneumonia and Respiratory Infections (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Molecular Medicine (136 citations), Applied Microbiology and Biotechnology (45 citations), Pharmacology (173 citations), Oncology (129 citations) and Epidemiology (113 citations). M. Macpherson has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Shampa Das, James G. Wright, Paul Newell, Todd Riccobene, Glen Clack, Neil J. Gallagher, Timothy J. Carrothers, Elizabeth B. Lamont, R.A. Seaton and Yuan Xiong. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, European Journal of Clinical Pharmacology, Cancer Research and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.